Registration
Opening
Session Chair
Vascular Tumor Targeting
Coffee Break
Session Chair
Novel Antagonists of Protease Activated Receptors 1: Unusual GPCRs Implicated in Cardiovascular Diseases
Identification of Functionally Selective Alpha2C-AR Agonists as Potential New Drugs for Treatment of Pain
Lunch and Poster Session
Session Chair
Pyrrolopyrimidine-Based P2X3 Antagonists for the Treatment of Pain
Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target
Coffee Break and Poster Session
Session Chair
Indole-carboxylic Acid Amides as Novel CETP Inhibitors: From Hit to Clinical Candidate and Beyond
Inhibitors of PKC-beta and GSK-3beta: A Tale of Two Kinases
Cocktail and Poster Session (Faculty of Pharmacy)
Start of parallel sessions
Session Chair
Sugars and Proteins
End of Conference
Departure by bus to visit the “Taittinger wine cellars” (for pre-registrated participants)
Visit of "Caves Taittinger"
Banquet
Banquet in the “Demeure des Comtes de Champagne” (18-22 rue de Tambour, 511100 Reims, near the City Hall)
In parallel:
14:00-15:30 - JOB Forum
The First NO- and Heam-independent Activator of Soluble Guanylate Cyclase for the IV Treatment of Acute Heart Failure
A Single Synthetic Peptide for Immunomodulating Lupus, a Complex Autoimmune Disease
Coffee Break
Session Chair
The Identification of Selective p38 MAPK Inhibitors with High Blood Potency Suitable for Clinical Development: The Discovery of Losmapimod
Telbivudine, a Potent and Specific Anti-HBV Nucleoside Analogue: From the Bench to its Marketing Approvals (Tyzeka®, Sebivo®)
Discovery of Inhibitors of MAPKAPK5, a Novel Target for Rheumatoid Arthritis
Conclusions
End of the Symposium